CN Patent

CN106674153A — 沃替西汀半盐酸盐晶体及其组合物与制备和应用

Assigned to Zhejiang Jingxin Pharmaceutical Co Ltd · Expires 2017-05-17 · 9y expired

What this patent protects

本发明提供了沃替西汀半盐酸盐晶体及其组合物与制备和应用。所述的沃替西汀半盐酸盐为沃替西汀和盐酸以摩尔比2:1形成的化合物，分子式为C 36 H 45 N 4 S 2 ·Cl，结构式以下式所示：。本发明的沃替西汀半盐酸盐晶体具有更高的纯度，可有效避免药物在制造、存储、运输等过程中引起的晶型转变的问题。本发明方法简单易行，利于工业化生产。

USPTO Abstract

本发明提供了沃替西汀半盐酸盐晶体及其组合物与制备和应用。所述的沃替西汀半盐酸盐为沃替西汀和盐酸以摩尔比2:1形成的化合物，分子式为C 36 H 45 N 4 S 2 ·Cl，结构式以下式所示：。本发明的沃替西汀半盐酸盐晶体具有更高的纯度，可有效避免药物在制造、存储、运输等过程中引起的晶型转变的问题。本发明方法简单易行，利于工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN106674153A
Jurisdiction
CN
Classification
—
Expires
2017-05-17
Drug substance claim
No
Drug product claim
No
Assignee
Zhejiang Jingxin Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.